Myelodysplastic syndromes, chronic myeloproliferative diseases, ative diseases

被引:14
作者
Vardiman, JW [1 ]
机构
[1] Univ Chicago, Dept Pathol, Chicago, IL USA
关键词
myelodysplastic syndromes; MDS; chronic myeloproliferative diseases; myelodysplastic/myeloproliferative diseases; chronic myelomonocytic leukemia;
D O I
10.1016/S0740-2570(03)00025-X
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
This article reviews the major diagnostic criteria for the myelodysplastic syndromes, chronic myeloproliferative diseases, and myelodysplastic/myeloproliferative diseases. Perhaps the most important message this article intends to convey is that the proper diagnosis and classification of myelodysplastic syndromes, chronic myeloproliferative diseases, and myelodysplastic/myeloproliferative diseases requires a multidisciplinary approach that correlates morphologic findings with clinical, genetic, and other laboratory information. Thus, the pathologist is central to the diagnosis of these disorders. Not only do pathologists have the morphologic skills to interpret peripheral blood and bone marrow aspirate smears and bone marrow biopsy specimens properly, but they often are responsible for interpretation of flow-cytometry and molecular genetic data as well. Pathologists are therefore in the best position to determine whether all the individual pieces of data fit together for the diagnosis under consideration. An additional important theme in the paper is that "well-prepared" blood and bone marrow aspirate smears and "adequate, well-processsed" bone marrow biopsy specimens are essential for the diagnosis. In the author's opinion, inadequate specimens usually account for most of the difficulties encountered in the proper diagnosis of these diseases. It is hoped that when an excellent specimen is available, the guidelines contained in this article may provide the pathologist with assistance in arriving at the most appropriate diagnosis. (C) 2003 Elsevier Inc. All rights reserved.
引用
收藏
页码:154 / 179
页数:26
相关论文
共 161 条
[41]   PROGNOSTIC IMPORTANCE OF IMMUNOPHENOTYPING IN ADULTS WITH ACUTE MYELOCYTIC-LEUKEMIA - THE SIGNIFICANCE OF THE STEM-CELL GLYCOPROTEIN CD34 (MY10) [J].
GELLER, RB ;
ZAHURAK, M ;
HURWITZ, CA ;
BURKE, PJ ;
KARP, JE ;
PIANTADOSI, S ;
CIVIN, CI .
BRITISH JOURNAL OF HAEMATOLOGY, 1990, 76 (03) :340-347
[42]   Validation of the WHO proposals for a new classification of primary myelodysplastic syndromes: a retrospective analysis of 1600 patients [J].
Germing, U ;
Gattermann, N ;
Strupp, C ;
Aivado, M ;
Aul, C .
LEUKEMIA RESEARCH, 2000, 24 (12) :983-992
[43]   Problems in the classification of CMML - dysplastic versus proliferative type [J].
Germing, U ;
Gattermann, N ;
Minning, H ;
Heyll, A ;
Aul, C .
LEUKEMIA RESEARCH, 1998, 22 (10) :871-878
[44]   Two types of acquired idiopathic sideroblastic anaemia (AISA): a time-tested distinction [J].
Germing, U ;
Gattermann, N ;
Aivado, M ;
Hildebrandt, B ;
Aul, C .
BRITISH JOURNAL OF HAEMATOLOGY, 2000, 108 (04) :724-728
[45]   Overexpression of FKBP51 in idiopathic myelofibrosis regulates the growth factor independence of megakaryocyte progenitors [J].
Giraudier, S ;
Chagraoui, H ;
Komura, E ;
Barnache, S ;
Blanchet, B ;
LeCouedic, JP ;
Smith, DF ;
Larbret, F ;
Taksin, AL ;
Moreau-Gachelin, F ;
Casadevall, N ;
Tulliez, M ;
Hulin, A ;
Debili, N ;
Vainchenker, W .
BLOOD, 2002, 100 (08) :2932-2940
[46]   FUSION OF PDGF RECEPTOR-BETA TO A NOVEL ETS-LIKE GENE, TEL, IN CHRONIC MYELOMONOCYTIC LEUKEMIA WITH T(512) CHROMOSOMAL TRANSLOCATION [J].
GOLUB, TR ;
BARKER, GF ;
LOVETT, M ;
GILLILAND, DG .
CELL, 1994, 77 (02) :307-316
[47]   Fas ligand expression in the bone marrow in myelodysplastic syndromes correlates with FAB subtype and anemia, and predicts survival [J].
Gupta, P ;
Niehans, GA ;
LeRoy, SC ;
Gupta, K ;
Morrison, VA ;
Schultz, C ;
Knapp, DJ ;
Kratzke, RA .
LEUKEMIA, 1999, 13 (01) :44-53
[48]   Receptor tyrosine kinase mutations in myeloid neoplasms [J].
Gupta, R ;
Knight, CL ;
Bain, BJ .
BRITISH JOURNAL OF HAEMATOLOGY, 2002, 117 (03) :489-508
[49]  
Hamblin TJ, 2002, BAS CLIN ON, V27, P15
[50]  
Hamblin TJ, 1996, SEMIN HEMATOL, V33, P150